Glenn Pierce
Directeur/Membre du Conseil chez VOYAGER THERAPEUTICS, INC.
Fortune : 183 019 $ au 31/05/2024
Postes actifs de Glenn Pierce
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2017 | - |
| Independent Dir/Board Member | 05/01/2017 | - | |
| Directeur Technique/Scientifique/R&D | 28/05/2021 | 02/06/2022 | |
| Hemostasis & Thrombosis Research Society | Corporate Officer/Principal | - | - |
| World Federation of Hemophilia | Directeur/Membre du Conseil | 01/01/2015 | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
| The International Society On Thrombosis & Haemostasis | Corporate Officer/Principal | - | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 25/01/2011 | - |
Historique de carrière de Glenn Pierce
Anciens postes connus de Glenn Pierce
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/02/2016 | 05/10/2022 |
| Independent Dir/Board Member | 08/02/2016 | 05/10/2022 | |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/08/2018 | 01/08/2020 |
| BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/03/2009 | 01/05/2014 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ | - | - | |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Glenn Pierce
| Case Western Reserve University | Doctorate Degree |
| Washington University in St. Louis | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 17 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 5 |
| Director/Board Member | 4 |
Sectorielle
| Health Technology | 11 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| AMGEN INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Selective Genetics, Inc.
 Selective Genetics, Inc. Medical SpecialtiesHealth Technology Selective Genetics, Inc. developed gene therapeutics and DNA devices for tissue repair and regeneration. The company was founded by Thomas S. Porter in 1998 and was headquartered Encinitas, CA. | Health Technology |
| Prizm Pharmaceuticals, Inc. | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
| National Hemophilia Foundation | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
| The International Society On Thrombosis & Haemostasis | |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
| World Federation of Hemophilia | |
| Hemostasis & Thrombosis Research Society | |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Glenn Pierce
- Expérience
